Literature DB >> 2164900

Do enzymatic analyses of serum triglycerides really need blanking for free glycerol?

R H Jessen1, C J Dass, J H Eckfeldt.   

Abstract

Distributions of concentrations of free glycerol in clinical plasma obtained for triglyceride assay were compiled to determine the frequency with which increased concentrations of free glycerol posed a potential problem for clinical interpretation of triglyceride results. Clinical histories were studied in patients with increased concentrations of free glycerol to ascertain possible reasons for the increase and to assess the relative clinical importance of glycerol-blank-corrected triglyceride results. Significant increases in free glycerol were very uncommon, usually occurring in patients receiving glycerol-containing hyperalimentation fluids, those receiving heparin (which causes both in vivo and in vitro increases in free glycerol), or those critically ill. Free glycerol was never increased significantly in a large outpatient population. Monitoring lipid metabolism in critically ill patients, or measuring true triglyceride concentrations in patients receiving glycerol-containing fluids, may represent rare exceptions for which glycerol-blank correction is necessary for accurate clinical diagnosis and management. We conclude that there is insufficient justification for the routine expenditure of extra time and reagents to correct most analytical enzymatic triglyceride methods for free glycerol.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164900

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Hyperketonaemia in glycerol kinase deficiency.

Authors:  D R Sjarif; L Dorland; W Sperl; T J de Koning; F A Beemer; B T Poll-The; M Duran
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

2.  Comparison between the triglycerides standardization of routine methods used in Japan and the chromotropic acid reference measurement procedure used by the CDC Lipid Standardization Programme.

Authors:  Masakazu Nakamura; Hiroyasu Iso; Akihiko Kitamura; Hironori Imano; Hiroyuki Noda; Masahiko Kiyama; Shinichi Sato; Kazumasa Yamagishi; Kunihiro Nishimura; Michikazu Nakai; Hubert W Vesper; Tamio Teramoto; Yoshihiro Miyamoto
Journal:  Ann Clin Biochem       Date:  2016-09-28       Impact factor: 2.057

3.  Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.

Authors:  Kathleen E Corey; Raj Vuppalanchi; Miriam Vos; Rohit Kohli; Jean P Molleston; Laura Wilson; Aynur Unalp-Arida; Oscar W Cummings; Joel E Lavine; Naga Chalasani
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

Review 4.  Lipoprotein Assessment in the twenty-first Century.

Authors:  Diego Lucero; Anna Wolska; Zahra Aligabi; Sarah Turecamo; Alan T Remaley
Journal:  Endocrinol Metab Clin North Am       Date:  2022-07-08       Impact factor: 4.748

5.  Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Authors:  Børge G Nordestgaard; Anne Langsted; Samia Mora; Genovefa Kolovou; Hannsjörg Baum; Eric Bruckert; Gerald F Watts; Grazyna Sypniewska; Olov Wiklund; Jan Borén; M John Chapman; Christa Cobbaert; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Kari Pulkki; Florian Kronenberg; Alan T Remaley; Nader Rifai; Emilio Ros; Michel Langlois
Journal:  Eur Heart J       Date:  2016-04-26       Impact factor: 29.983

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.